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Abstract
Summary: Tens of thousands of reproducibly identified GWAS (Genome-Wide Association 
Studies) variants, with the vast majority falling in non-coding regions resulting in no eventual pro-
tein products, call urgently for mechanistic interpretations. Although numerous methods exist, 
there are few, if any methods, for simultaneously testing the mediation effects of multiple corre-
lated SNPs via some mediator (e.g. the expression of a gene in the neighborhood) on phenotypic 
outcome. We propose multi-SNP mediation intersection-union test (SMUT) to fill in this methodo-
logical gap. Our extensive simulations demonstrate the validity of SMUT as well as substantial, up 
to 92%, power gains over alternative methods. In addition, SMUT confirmed known mediators in a 
real dataset of Finns for plasma adiponectin level, which were missed by many alternative meth-
ods. We believe SMUT will become a useful tool to generate mechanistic hypotheses underlying 
GWAS variants, facilitating functional follow-up.
Availability and implementation: The R package SMUT is publicly available from CRAN at https://
CRAN.R-project.org/package¼SMUT.
Contact: xiaojinz@email.unc.edu or jfine@email.unc.edu or yunli@med.unc.edu
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Genome-wide association studies (GWASs) have been successful for
detecting genetic variants associated with complex diseases and
traits. The effects of genetic variants either individually or even in
aggregation on complex traits are typically small to moderate at
best. More importantly, the vast majority of GWAS variants reside
in non-coding regions, with largely elusive underlying mechanism.
Expression quantitative trait loci (eQTL) analysis (Lloyd-Jones
et al., 2017; The GTEx Consortium, 2015; Yang et al., 2017) has
facilitated functional interpretation. Transcriptome-wide associ-
ation studies (TWAS), which identify association between imputed
gene expression and trait, also generates mechanistic hypotheses
(Gamazon et al., 2015; Gusev et al., 2016)
(BioRxiv: https://doi.org/10.1101/286013). Such integration of
genotype, gene expression and phenotype information from GWAS
and eQTL datasets will fundamentally advance our knowledge of
molecular mechanisms of complex disorders and traits. Several ex-
cellent review papers exist for causal relationship inference in the
context of genetic mapping for complex traits (Ainsworth et al.,
2017; Civelek and Lusis, 2014).
Integrative genomic studies enable mechanistic interpretations,
e.g. via either the methods of instrumental variable(s) [IV(s)] and/or
mediation analysis. Mendelian randomization (MR) framework
(Lawlor et al., 2008; Smith and Ebrahim, 2003) treats genetic var-
iant(s) as the IV(s) to assess causal effects of genetic variants through
some mediator(s) of interest [e.g. expression levels of some gene(s)]
on the trait of interest. Classic MR methods make several key
assumptions including complete mediation, where single nucleotide
polymorphisms (SNPs) must be marginally independent of the con-
founding between mediator and outcome, and a priori knowledge
that the causal flow is from SNP to mediator but not the reverse
(Lawlor et al., 2008). Violating the assumptions leads to invalid IV
analysis and biased inference. Some more recent MR methods allow
relaxation of certain key assumption(s). Such relaxation(s), how-
ever, are at costs. For example, MR-Egger (Barfield et al., 2018;
Bowden et al., 2015) relaxes the complete mediation assumption
and allows multiple IVs/SNPs by first analyzing each IV individually
and then meta-analyzing individual IV results. However, MR-Egger
assumes that these multiple SNPs are uncorrelated, limiting its appli-
cation to a typical locus where multiple partially dependent SNPs
exist.
Another drawback of MR methods is that they cannot distin-
guish between mediation and pleiotropy, the phenomenon of one
SNP effecting on multiple outcomes (at either molecular or organism
level) (Fig. 1). Since pleiotropy is commonly observed (Solovieff
et al., 2013), MR methods are not preferred, when the goal is to
infer mediation or to generate mechanistic hypotheses. The recent
CaMMEL method (BioRxiv: https://doi.org/10.1101/219428),
extending the MR-Egger framework, allows correlated IVs and in-
complete mediation beyond the multiple mediators modeled and, to
distinguish mediation from pleiotropy. CaMMEL, designed for mul-
tiple mediators modeled simultaneously, is sub-optimal for single
mediator analysis. In addition, CaMMEL assumes the presence of at
least one eQTL since it tests the effect of mediators on phenotype, in
contrast to testing SNP(s) effect via mediator(s) on phenotype.
Similar to CaMMEL, MR-BMA (BioRxiv: https://doi.org/10.1101/
396333), also adopts a Bayesian framework, leverages summary sta-
tistics, and accommodates multiple mediators and multiple IVs.
Unlike CaMMEL, MR-BMA assumes uncorrelated IVs and com-
plete mediation through the modeled mediators, and aims primarily
at selecting true mediators from a set of correlated mediators.
Besides TWAS and MR, other mechanism elucidating methods in
the recent literature include causal inference test (CIT) (Millstein
et al., 2009) and Huang et al. (Huang, 2015; Huang et al., 2014).
CIT employs a regression-based framework to test for complete medi-
ation, which is a largely unrealistic scenario. The methods of Huang
et al. adopt a kernel regression framework and uses variance compo-
nent score statistic (Lin, 1997) to test for mediation. However, these
methods also assume that genetic variants tested contain a priori
known eQTL(s), and similar to CaMMEL, test the effect of mediators
on phenotype, in contrast to testing indirect SNP(s) effect through
mediators on phenotype.
Popular classic mediation approaches include causal steps, differ-
ence method and product method (MacKinnon et al., 2007;
VanderWeele, 2016). The causal steps approach performs multiple
tests involved in a causal chain. The difference method is based on the
difference in the coefficient estimate of the treatment (here, a SNP) be-
fore and after including the mediator in the regression model. The
product method, such as the Sobel test (Sobel, 1982), explicitly tests
the product of the treatment coefficient in the mediator model and
the mediator coefficient in the outcome model. These methods, com-
monly adopted to test the mediation effect of a single genetic variant
on a trait through a single mediator, have been evaluated by Barfield
et al. (2017). However, it is unclear that such methods can be adapted
to integrative genomic settings with high dimensional SNPs.
In short, to the best of our knowledge, few, if any, existing meth-
ods can simultaneously accommodate incomplete mediation as well
as multiple correlated SNPs, when complete individual level data
(including genotype, mediator and phenotype information) are avail-
able. To fill the gap, we propose here multi-SNP mediation intersec-
tion-union test (SMUT) to explicitly accommodate both direct and
indirect (via mediator) effect of multiple (in the order of hundreds to
thousands) correlated SNPs on phenotype of interest. SMUT is a flex-
ible, regression-based approach that evaluates the joint mediation
effects of multiple genetic variants on some trait of interest through a
single mediator. SMUT extends the classic framework of Baron and
Kenny (1986) to allow multiple treatment variables (in our context,
multiple genetic variants). Leveraging the intersection-union test
(IUT) (Berger and Hsu, 1996), SMUT decomposes mediation effects
using two separate regression models. One is the mediator model
where we regress the mediator on multiple genetic variants. For this
mediator model, SMUT adopts the SKAT (Lee et al., 2014; Wu et al.,
2011) framework to handle a potentially large number of genetic var-
iants in a statistically and computationally efficient manner. The
other is the outcome model where we regress the outcome on both
the mediator and multiple genetic variants. Classic regression models
fail for the outcome model due to the high dimensionality of the
SNPs. To solve this issue in SMUT’s outcome model, we adopt a
mixed effects model and the Rao’s score test (Engle, 1984;
Radhakrishna Rao and Bartlett, 1948) for mediation testing. Our ex-
tensive simulations and real data analysis demonstrate the advantages
of SMUT over alternative methods. For example, with controlled
Type-I error, we show up to 92% power gain in simulations. More
importantly, in real data analysis, SMUT confirms mediations at sev-
eral well-established positive control loci while most of the alternative
methods failed to reveal any of the relationships.
2 Materials and methods
2.1 SMUT
SMUT is a powerful test for the joint mediation effects of multiple
genetic variants on a trait through a single mediator. The multiple
genetic variants can be in a region, sub-locus defined by genes, or
moving windows across the genome.
2.2 Notation and data set-up
Without loss of generality, we assume that we have three types of data.
Specifically, genotypes, gene expression measurements (can be other
types of mediators such as metabolite levels or protein abundances) and
phenotypic trait are available. Let G ¼ G1;G2; . . . ;ð GqÞ be the n by q
genotype matrix, where n is sample size; q is the total number of mark-
er and Gj ¼ ðG1j;G2j; . . . ;GnjÞT is the vector of genotypes for the n
samples at marker j, j ¼ 1; 2; . . . ;q. We consider an additive model
with Gij taking values 0, 1, 2, measuring the number of copies of the
minor allele. Suppose in total there are l genes M;Mð2Þ; Mð3Þ; . . . ;MðlÞ,
with the first notation M having no superscript. Here,
M ¼ M1;M2; . . . ;Mnð ÞT , is the vector of expression values of a given
gene (the mediator) for n samples. Similarly, Mð2Þ; . . . ;MðlÞ are the vec-
tors of expression values of the other ðl  1Þ genes (i.e. mediators). Let
Y ¼ ðY1;Y2; . . . ;YnÞT be the vector of phenotypic trait.
2.3 SMUT model and test for joint mediation effects
SMUT models the effects of genetic variants on the trait mediated
by the expression level of a single gene. We start with considering a
Fig. 1. Directed acyclic graph for mediation and pleiotropy. (A) Red arrows in-
dicate the mediation effect of the genotype on the outcome through the medi-
ator. (B) Orange arrows indicate the pleiotropy
more general model with multiple genes expression levels via the fol-
lowing regression models:
Y ¼ a1 þMhþ
Xl
k¼2
MðkÞhðkÞ þGcþ 1 (1)
M ¼ a2 þGbþ 2
Mð2Þ ¼ að2Þ þGbð2Þ þ ð2Þ
Mð3Þ ¼ að3Þ þGbð3Þ þ ð3Þ
. . .




where c ¼ ðc1; c2; . . . ; cqÞTare the direct effects of the q genetic var-
iants; bh measures the indirect effects mediated by M for the mul-
tiple genetic variants. Similarly bðkÞhðkÞ measures the indirect effects
mediated by MðkÞ; k ¼ 2; 3; . . .;l:
Substituting the M;Mð2Þ;Mð3Þ; . . . ;MðlÞ with the values in (2), we have
Y ¼ ~a þGbhþG~c þ ~ (3)
where ~a ¼ a1 þ a2hþ
Pl
k¼2 a
ðkÞhðkÞ, ~c ¼ cþ
Pl
k¼2 b




ðkÞðkÞ Equation (3) shows that indirect effects mediated
by Mð2Þ;Mð3Þ; . . . ;MðlÞ would be absorbed by the direct effects ~c if
we only model gene M: Therefore, without loss of generality, we
only consider the mediation analysis for a given single gene expres-
sion level and consider the regression models below
Y ¼ a1 þMhþGcþ 1 Outcome model (4)
M ¼ a2 þGbþ 2 Mediator model (5)
where 1  Nð0; r21IÞ, 2  Nð0; r22IÞ, and we assume that 1 and
2 are independent; otherwise their correlation would make them-
selves mediator-outcome confounders which violates the key as-
sumption for mediation analysis (MacKinnon et al., 2007;
VanderWeele, 2016).
Here c measures effects from two sources: direct effects of the q
genetic variants on outcome; and indirect effects of genetic variants
via mediators other than M. For presentation brevity and clarity, we
hereafter use direct effects to refer to the aggregated effects from the
above two sources. We are interested in testing the mediation effect,
of the q genetic variants via mediator M. Specifically, we test the
null hypothesis H0 : bh ¼ 0, which is divided into two sub-
hypotheses, Hh0 : h ¼ 0 and H
b
0 : b ¼ 0: This then can be convenient-
ly solved by the IUT (Supplementary Section 1).
2.4 Testing b in the mediator model and h in the
outcome model
Many of the testing methods for association between multiple genetic
variants and the trait can be applied here. We adopt the SKAT frame-
work, a de facto locally powerful test (Ionita-Laza et al., 2013; Wu
et al., 2010, 2011), which efficiently accommodates large numbers of
genetic variants, including both common and rare variants.
The outcome model is also high dimensional with multiple genet-
ic effects and the mediator. Classic regression models tend to fail for
such models. As a solution, we employ the following mixed effects
model to reduce the dimension of parameters.
cji:i:d: Nðlc; r2c Þ
ii:i:d: Nð0; r2 Þ







We adopt an Expectation–maximization algorithm to obtain
maximum likelihood estimate under the null hypothesis and derive a
score test statistic for the fixed effect h in the presence of a high
dimensional SNPs, modeled as random effects (Supplementary
Section 2).
2.5 Simulations
To evaluate the performance of SMUT in comparison with alterna-
tive methods, we carried out extensive simulations to investigate
power and Type-I error. We first simulated 20 000 European-like
chromosomes in a 1 Mb region, using the COSI coalescent model
(Schaffner et al., 2005) to generate realistic data in terms of allele
frequency, linkage disequilibrium and population differentiation.
The final dataset had 23 889 SNPs in a 1 Mb region. We constructed
10 000 pseudo-individuals by pairing up the 20 000 simulated chro-
mosomes. To evaluate power and Type-I error, we generated 200
datasets with 1000 samples each by sampling without replacement
from the entire pool of 10 000 samples above. Simulations were
restricted to the 2891 SNPs with minor allele frequency (MAF)
1%.
The outcome (trait) and the mediator were generated via the fol-
lowing outcome model (7) and mediator model (8), respectively.
Y ¼ a1 þMhþ ðsSNPs and oSNPsÞcþ 1 (7)
M ¼ a2 þ ðsSNPs and mSNPsÞbþ 2: (8)
Where 1  N 0; 1ð Þ; 2  N 0; 1ð Þ; b ¼ b1; b2; . . . ; bq
 T ; c ¼ ðc1;
c2; . . . ; cqÞT ; bji:i:d:cbN 2; 2ð Þ; cji:i:d:ccN 2; 2ð Þ; j ¼ 1; 2; . . . ; q:
We set cc ¼ 0:2 to evaluate the performance of SMUT and alter-
native methods under the scenario of pleiotropy. Specifically, the
shared SNPs (sSNPs) between the two models are those that influ-
ence both the mediator and the outcome trait. The outcome (or me-
diator) specific SNPs only contribute to the trait (or mediator). The
causal SNPs are the union of the sSNPs, mediator specific SNPs
(mSNPs) and outcome specific SNPs (oSNPs). We considered two
scenarios in terms of causal SNP density: sparse and dense (Table 1),
with 10 and 1000 causal SNPs, respectively. The set of (10 or 1000)
causal SNPs, common across the 200 datasets, were randomly
selected from the 2891 SNPs with MAF  1%. b and c, again
fixed across the 200 datasets, were independently drawn from a nor-
mal distribution with mean and variance both being 2. Error terms
1 and 2 were independently generated from standard normal dis-
tribution and were separately simulated for each of the 200 datasets.
In the simulations, we tested the joint mediation effects of these
2891 SNPs on the trait using SMUT and other methods including
adapted Huang et al.’s method, adapted LASSO (Tibshirani, 1996),
adapted CaMMEL, Sobel test and SMR (Zhu et al., 2016). The
Huang et al.’s method only tests mediator effect in the outcome
model, assuming a priori the presence of SNPs’ effects on mediator
(i.e. non-zero b), adopting a kernel framework where effect(s) of
interest are treated as random and SNPs as fixed (Huang, 2015;









Sparse 10 4 3 3
Dense 1000 334 333 333
Note: The sparse(dense) scenario is to simulate datasets based on a
small(large) number of causal SNPs. Causal SNPs are the union of sSNPs,
mSNPs and oSNPs. sSNPs have effects on both mediator and outcome.
Mediator(outcome) specific SNPs have effects only on mediator(outcome).
All these SNPs are randomly selected from the 2891 SNPs with MAF1%.
Huang et al., 2014), in contrast to our outcome model where SNPs
are treated as random and mediator of interest as fixed. For fair
comparisons across methods, i.e. testing both b and h, we applied
the original Huang et al. for the outcome model and SKAT for the
mediator model, then combined tests from the two models via IUT,
integrating the variance component score test in the outcome model
(from the original Huang et al.) and score test from SKAT in the me-
diator model. The adapted LASSO employs LASSO for variable se-
lection in the outcome model and applies IUT using regular
regression with the selected variables in the outcome model and all
the variables (i.e. genetic variants) via SKAT framework in the medi-
ator model. The adapted CaMMEL applies IUT on CaMMEL
results to test h in the outcome model and SKAT result to test b in
the mediator model. Since Sobel test and SMR can only model one
single SNP at a time, we tested each SNP separately and applied
Bonferroni adjustment. We applied and compared with the adapted
versions of Huang et al., CaMMEL and LASSO because the corre-
sponding original methods only test h in the outcome model. For all
the adapted versions, we utilize SKAT to test b in the mediator
model to be maximally comparable with our SMUT results. In other
words, adapted Huang et al. is SKAT þ original Huang et al. with
SKAT corresponding to the testing strategy in the mediator model
and original Huang et al. to the testing strategy in the outcome
model. Similarly, for CaMMEL and LASSO, we use adapted
CaMMEL and SKATþCaMMEL exchangeably; adapted LASSO
and SKATþCaMMEL exchangeably.
As detailed above, we simulated causal SNPs only from the pool
of common (MAF  1%) SNPs. By default, we tested all common
SNPs in the region to mimic the realistic scenario where we have
relatively little information regarding which SNPs are causal, at an
established GWAS locus. To test the robustness and generalizability
of the methods, we considered two alternative testing strategies each
with a reduced set of genetic variants modeled. For the first testing
strategy, we assume prior knowledge of eQTL SNPs (union of
shared and mediator specific causal SNPs) and test only these eQTL
SNPs. On the positive side, such an approach results in a reduced
model with causal SNPs considered only. On the negative side, a
subset of causal markers (specifically, the outcome specific causal
SNPs) are not modeled. The second strategy tests SNPs with
MAF  5%, thus missing true causal SNPs with MAF between 1
and 5%.
3 Results
3.1 Type-I error in simulations
We evaluated SMUT along with alternative methods in simulations.
SMUT manifested controlled Type-I error rates, at a ¼ 0.05 level,
regardless of causal SNP density, as shown in Figures 2 and 3 for
sparse and dense scenarios, respectively. Note that the first panel
(cb ¼ 0) and the left-most point (h ¼ 0) in other panels (cb 6¼ 0) all
correspond to the null of no mediation through the mediator.
Adapted Huang et al.’s method also showed protected Type-I error.
In contrast, Sobel test and SMR showed substantial inflation in
Type-I error, particularly when cb is large. For example,
when cb ¼ 0:2, h ¼ 0 and sparse causal SNPs, Type-I error rates for
Sobel test and SMR are 90% and 100%, respectively. Such marked
inflation in Type-I error is likely due to the more severe violation of
the assumption of no pleiotropy, made by these two methods, as cb
increases. Adapted CaMMEL also showed Type-I error inflation.
For example, among sparse causal SNPs when cb ¼ 0:2, h ¼ 0, the
Type-I error rate is 100%. We suspect such inflation is due to the
fact that CaMMEL was developed for joint testing of multiple medi-
ators via a Bayesian framework to borrow information across medi-
ators. Thus, when testing one single mediator, lack of information
in the Bayesian inference can lead to Type-I error inflation. Adapted
LASSO had severe Type-I error inflation when the causal SNPs were
dense (Fig. 3). For instance, when cb ¼ 0:05 and h ¼ 0 Type-I error
rate is 75%. This is likely due to the violation of LASSO’s sparsity
assumption (Zhao and Yu, 2006).
Assuming normality of cjðj ¼ 1; 2; . . . ;qÞ in the outcome model
may not be strictly correct when some SNPs are non-causal
(cj exactly zero) while others are causal. A mixture distribution
would be more appropriate. But our approach gives valid tests in
simulations even when the assumption may not be valid
(Supplementary Figs S1 and S2).
3.2 Power in simulations
We assessed power only for tests with protected Type-I error, name-
ly our SMUT and adapted Huang et al. SMUT demonstrated large
power gains when the causal SNPs were either sparse or dense. For
example, dense causal SNPs when cb ¼ 0:2, h ¼ 0:15, SMUT and
Fig. 2. Power and Type-I error under sparse causal SNPs scenario. The x-axis
is the true mediator effect(h) on the outcome. The y-axis is the power or Type-
I error. Sub-figures vary in cb value. cb ¼ 0 (top-left sub-figure) or h ¼ 0 (left-
most points in each sub-figure) are null settings where y-axis represents the
corresponding Type-I error. When cb 6¼ 0 and h 6¼ 0, it is under alternative hy-
pothesis and y-axis represents the corresponding power
Fig. 3. Power and Type-I error under dense causal SNPs scenario. X-axis and
y-axis are the same as in Figure 2
adapted Huang et al. had 97% and 5% power, respectively and the
power gain was 92%. Power gains appeared more profound
with increasing cb; likely because adapted Huang et al. became
very conservative when the pleiotropy effect (cb) was large. Details
and results of testing robustness of SMUT are in Supplementary
Section 3.
3.3 Real data application: METSIM dataset
The METSIM study is a population-based study with 10 197 males,
aged 45–73 years, randomly selected from the population register of
Kuopio town in eastern Finland (population 95 000) (Stancakova
et al., 2009). We analyzed genotype, gene expression and phenotype
data in the subset of 770 participants with gene expression measure-
ments from subcutaneous adipose tissue (Civelek et al., 2017). The
outcome of interest is plasma adiponectin levels. All METSIM sub-
jects participated in a 1-day outpatient visit to the Clinical Research
Unit at the University of Kuopio for data collection, which included
an interview for their medical history and a blood sample following
a 12-h fast. Plasma was measured using the Human Adiponectin
Elisa kit (LINCO Research).
Here, we tested two ‘positive control’ loci for which our previous
study (Civelek et al., 2017) provided mechanistic evidences. The first
locus was the adiponectin-associated GWAS locus ARL15 (with the
index SNP rs6450176 being an ARL15 intronic variant), where the
association might be mediated, at least in part, through altered ex-
pression of the FST gene located further (>521 kb from rs6450176)
away instead of ARL15 (Civelek et al., 2017; Martin et al., 2017).
The second locus was the ADIPOQ locus, also associated with adi-
ponectin levels.
We first extracted SNPs within 61 Mb of the corresponding
genes, ARL15 union FST and ADIPOQ union ADIPOQ-AS1 for
the two loci, respectively. In terms of phenotypic outcome, namely
adiponectin, trait levels were inverse normal transformed after
adjusting for age and BMI, following our previous work (Civelek
et al., 2017). For the first ADIPOQ locus, we tested 286 SNPs with
adiponectin association P-value <5108, using SMUT, adapted
Huang et al.’s method, adapted CaMMEL, CIT, SMR and Sobel
test. Results are summarized in Table 2. Huang et al.’s method
returned no results (therefore not shown in Table 2) because it
required standardized genotype data which can be undefined for
low frequency SNPs. SMUT and SMR both showed significant me-
diation effects through ADIPOQ on adiponectin: SMUT for two
probesets and SMR for two probesets. For the second FST-ARL15
locus, we tested 366 SNPs with MAF  1% and adiponectin associ-
ation P-values <0.01. Only SMUT detected significant mediation
effects through FST (but not ARL15) on the adiponectin. These
results suggest that our SMUT is more powerful for detecting genu-
ine mediation effects.
4 Discussion
We propose SMUT, a flexible regression-based approach that tests
the joint mediation effects of multiple genetic variants on an outcome
through a given mediator (e.g. gene). We demonstrate, through exten-
sive simulations, that SMUT preserves Type-I error rate. Our IUT ap-
proach essentially takes the maximum of the P-values from separately
testing b being zero and h being zero, with the Type-I error for the
likely more influential b part protected by the well-established SKAT
method. More stringent filtering can be applied by adopting multiple
testing adjustments such as Bonferroni or FDR correction. SMUT is
statistically more powerful than alternative methods including
adapted Huang et al.’s method, adapted LASSO, adapted CaMMEL,
Sobel test and SMR.
SMUT has several major advantages over alternative methods.
First, as a regression-based approach under the mediation analysis
framework, SMUT can distinguish mediation from pleiotropy.
Second, SMUT generalizes the framework of Baron and Kenny to
multiple genetic variants, while methods including SMR and Sobel
test can only test one single variant at a time. Third, SMUT naturally
accommodates correlation (or LD) among genetic variants while
many methods including MR-Egger assume genetic variants under
testing are uncorrelated. Fourth, SMUT enables relatively large
number of SNPs by fitting a mixed effects model, while sparse fixed
effects model (e.g. LASSO) relies on sparsity of the true causal SNPs
and may cause inflated Type-I error if violating the sparsity assump-
tion. Finally, SMUT, even its present form, can handle mediators
other than gene expression (as presented in the manuscript). For ex-
ample, molecular measurements such as chromatin spatial organiza-
tion, histone modification, transcription factor binding affinity and
protein abundance can all serve as valid mediators (Schmitt et al.,
2016; Sun et al., 2016; The GTEx Consortium, 2015; Xu et al.,
2016).
Conceptually, TWAS methods are also designed to elucidate
mechanisms regarding the mediation effects of multiple SNPs via
gene expression on phenotypic outcome. However, as previously
mentioned, TWAS is designed for scenarios where eQTL and GWAS
Table 2. Results from the METSIM study
P-values
Probesets No. of SNPs Gene SMUT Adapted CaMMEL CIT SMR Sobel test
11734558_a_at 286 ADIPOQ 0.07 0.09 1.0 0.08 0.07
11734559_x_at 286 ADIPOQ 0.01 0.09 0.54 0.03 0.07
11734560_x_at 286 ADIPOQ 0.90 0.09 1.0 0.08 1.0
11752564_x_at 286 ADIPOQ 0.04 0.09 0.89 0.03 0.27
11724032_a_at 366 FST 0.02 0.09 1.0 1.0 1.0
11732712_a_at 366 FST 0.01 0.09 1.0 1.0 1.0
11732713_at 366 FST 0.03 0.09 1.0 1.0 1.0
11731654_at 366 ARL15 1.0 0.09 1.0 1.0 1.0
11757014_a_at 366 ARL15 0.13 0.09 1.0 1.0 1.0
Note. We used SMUT and other alternative methods (adapted CaMMEL, CIT, SMR and Sobel test) to test two loci, the ARL15 locus and the ADIPOQ locus.
SNPs within corresponding genes, ARL15 union FST and ADIPOQ union ADIPOQ-AS1 for the two loci respectively, are extracted. For the ADIPOQ locus,
both SMUT and SMR showed significant mediation effects through ADIPOQ on adiponectin. For the ARL15 locus, only SMUT detected significant mediation
effects through FST (but not ARL15) on the adiponectin. The P-values are adjusted using Bonferroni correction. Numbers in bold are the P-values less than 0.05.
datasets are from two separate sets of study participants. Our SMUT
method is designed for the scenario where we have genotype, mediator
and phenotype information measured in the same study subjects.
Therefore, we have not directly compared with TWAS methods and
deem our SMUT and TWAS useful for different data scenarios.
SMUT can be further extended in several directions. It can be
extended to accommodate binary, survival or longitudinal pheno-
typic outcome, given its regression-based framework. These exten-
sions, however, are non-trivial because the outcome model will be a
generalized linear mixed model with random effects (for SNPs) that
are high dimensional, and are shared across samples unlike in stand-
ard repeated measures settings. These complexities entail the explor-
ation of Laplace approximation of the likelihood or partial
likelihood function for proper and computationally tractable testing
of theta, which we are actively pursuing and warrants separate pub-
lication. We can also extend SMUT to simultaneously model mul-
tiple mediators, which may yield improved power for testing at the
price of stronger modeling assumptions.
With more genotyping-based GWAS and large whole genome
sequencing efforts underway, the already dauntingly large number
of GWAS variants will continue to increase. Approaches generating
hypotheses on the mechanisms underlying these variants are impera-
tive. We anticipate SMUT will be a powerful tool in this post-
GWAS era to help with bridging the functional gap of GWAS, pri-
oritizing functional follow-up and disentangling the potential causal
mechanism from DNA to phenotype for a new drug discovery and
personalized medicine.
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